Neurosurgery Clinic, Pauls Stradins Clinical University Hospital, Latvia.
Medicina (Kaunas). 2012;48(10):521-4.
Studies on decompressive craniectomy (DCE) after a malignant middle cerebral artery (MCA) stroke in selected population show an increased probability of survival without increasing the number of very severely disabled. Cerebral infarct volume (CIV) as a triage criterion for performing surgery has not been discussed in literature. The aim of this study was to investigate the value of CIV and initial National Institutes of Health Stroke Scale (NIHHS) and Glasgow Coma Scale (GCS) scores as possible triage criteria in the surgical treatment of patients with "malignant" MCA stroke.
According to the study protocol, 28 patients with a malignant MCA stroke were included and analyzed prospectively. The patients were randomly divided either into the DCE plus best medical treatment (BMT) group or BMT alone group. CIV and NIHHS and GCS scores were measured at time of enrollment in every case. Clinical outcome was evaluated 1 year after the treatment.
Six patients survived: 5 in the DCE group (none of them was older than 60 years) and 1 in the BMT group (P=0.03/0.06). Among survivors, none had a cerebral infarct volume of more than 390 cm(3) (P=0.05). All survivors in the DCE group had favorable outcomes. There was no significant difference in the NIHSS and GCS scores between the groups and survivors/nonsurvivors (P>0.05).
Decompressive surgery in the selected patients is likely to increase the probability of survival with a favorable outcome without increasing the number of severely disabled survivors. Patients with CIV of more than 390 cm(3) may be bad candidates for DCE, and the prognosis is likely to be bad regardless the treatment strategy. The initial NIHHS and GCS scores did not prove any prognostic value in outcome.
在选择人群中进行去骨瓣减压术(DCE)治疗恶性大脑中动脉(MCA)卒中的研究表明,在不增加极重度残疾人数的情况下,提高生存率的可能性增加。手术作为分流标准的脑梗死体积(CIV)尚未在文献中讨论过。本研究的目的是探讨 CIV 以及初始国立卫生研究院卒中量表(NIHHS)和格拉斯哥昏迷量表(GCS)评分作为“恶性”MCA 卒中手术治疗可能的分流标准的价值。
根据研究方案,前瞻性纳入并分析了 28 例恶性 MCA 卒中患者。患者随机分为 DCE+最佳药物治疗(BMT)组或 BMT 组。每位患者在入组时均测量 CIV 和 NIHHS 和 GCS 评分。治疗 1 年后评估临床结果。
6 例患者存活:DCE 组 5 例(均不超过 60 岁),BMT 组 1 例(P=0.03/0.06)。存活者中,无一例 CIV 超过 390cm³(P=0.05)。DCE 组所有存活者均预后良好。两组之间以及幸存者/非幸存者之间的 NIHSS 和 GCS 评分无显著差异(P>0.05)。
选择性手术治疗可能会增加生存率和良好预后的可能性,而不会增加极重度残疾幸存者的人数。CIV 超过 390cm³的患者可能不适合 DCE,无论治疗策略如何,预后可能都很差。初始 NIHHS 和 GCS 评分在预后方面没有证明任何预后价值。